中文The best packaging ideas are almost always the ones that make you slightly annoyed you did not think of them.
Here is one. A standard prefilled syringe has a plunger rod sticking out the back, extended so there is room for the medication inside. That rod does nothing during shipping and storage except take up space. A lot of space.
So Pacto Medical moved it. Instead of inserting the rod into the back, they clip it onto the side of the barrel. When you are ready to use it, you unclip it, give it a quarter or half turn, and it works exactly like any other syringe.
The result is a syringe that is about 40% smaller for the same dose of medication. They call it Slimshot.
The number that gets a CFO’s attention
Ian Speers, CEO and co-founder of Pacto Medical, estimates that at scale, Slimshot unlocks up to 35% in total supply chain cost reductions.
That figure is not one saving but a stack of them, each boringly logical:
- Less secondary packaging — less flow wrap, fewer cartons per unit
- Lower sterilization costs, because terminal sterilization is often priced by volume
- Reduced shipping and storage cost, especially in cold chain
- Lower disposal costs for unused product, which is also frequently priced by volume
That sterilization detail is the one packaging people tend to miss: pay by volume, fit more syringes per box, and you have cut a cost line that has nothing to do with materials.
Regulatory: the smartest part of the whole design
Anyone who has worked near pharma packaging knows the real question is not “is this clever?” It is “how many years of regulatory work does this cost me?”
Robert Halvorsen, Pacto Medical’s Chief Technical Officer and Lead Engineer, has a three-part answer that is genuinely well constructed.
First, nothing touching the drug changed. The barrel, thread insert and plunger stopper remain standard materials, identical to conventional prefilled syringes. Only the plunger rod — the part that pushes against the stopper — is different.
Second, Pacto operates as a subcomponent designer. Approval happens at the fill-finish level, by the pharmaceutical manufacturer using their existing process.
Third, existing approvals can be modified rather than redone. For products like sterile saline, accommodating the new plunger rod is relatively low effort compared with a full approval.
Halvorsen is straight about the limits, which builds credibility. Sterile saline sits in a grey area — either a 510(k) or an abbreviated new drug application. Move to emergency medicines like ketamine, epinephrine or TXA and it becomes a drug-led product requiring drug-led approval. He says they have done the legwork and are confident the side-mounted rod is no substantial hurdle.
The production line barely changes
This is where the design goes from clever to commercially serious.
Speers walks through it: the barrel gets filled, visually inspected, labelled. All identical. Then instead of inserting a plunger rod in the top and twisting, you snap it on the side. After that, flow wrap or other secondary packaging, into boxes.
“So the change is really at the far, far end of the manufacturing process, and it’s very minimal. We don’t want to get in the way and cause a lot of changing to tooling or filling machines earlier on.”
One station changes. Nothing upstream. That is the difference between an idea a manufacturer will consider and an idea they will politely decline.
It works with both plastic and glass — material agnostic, which they need to be since drug compatibility varies.
Clinicians figured it out with zero instructions
Now the most convincing part, because it addresses the obvious objection: you have added a step for someone in an emergency.
Pacto tested with hundreds of clinicians over years, and their test is delightfully ruthless. Hand it to someone at a conference who has never seen it, give them no instructions whatsoever, and ask how they would assemble it.
Speers describes the reaction: they look at it for a second, take the rod off, look at the threads, and go “Maybe that… is that it?” Yes. That’s it.
The results: 100% first-time success, assembly in 2 to 4 seconds on average, successful administration in mock settings. As Speers puts it, “it’s quite been quite a process to get there, but that’s really important that we’re not diminishing the clinician’s experience.”
The frustration this actually solves
Here is the section that turned this from an efficiency story into something with real stakes.
Speers, who still works as an EMT and search-and-rescue technician, describes what clinicians in space-constrained environments currently do with bulky saline flushes. In a helicopter, disaster response kit, ambulance or ER cart, the prefilled syringe is the longest item in the bag. So people improvise:
- Carry an empty syringe and draw saline from an IV bag or vial at point of use — extra steps, extra hassle
- Downgrade from 10ml to a 3ml or 5ml because that is what fits — compromising clinical capacity
- Physically disassemble syringes before a shift and duct-tape or rubber-band the rod alongside
- Worst case, keep one plunger rod for three or five syringes and reassemble as needed
That last one should make anybody uneasy. Speers is diplomatic about it — “not best clinical practice” — but the point lands hard:
“We’re not forcing them into corners where they’re needing to do these weird and often dangerous DIY solutions.”
And it scales beyond ambulances. Health workers delivering vaccines in remote or low-resource settings can carry a fixed number of refrigerated boxes per day. Fit more doses in each box and you change what that worker can accomplish that day. Speers, whose background includes medical logistics for nonprofits and governments across Africa and the Middle East, came to this because prefilled syringes were often unavailable there — too bulky, too expensive. He calls it a health equity issue, and that does not feel like an overstatement.
Cost, honestly
Credit to Halvorsen for not overselling. Right now, it costs a little more. Not because of materials — the plunger rod uses the same amount of plastic — but because they are not at scale. Initial production is 4 to 5 million units per year of 10ml saline flushes, against an existing market of billions.
“So the short answer is right now it’ll be more expensive, but eventually it’ll get cheaper and it’ll get cheaper than the existing prefilled syringes.”
The platform spans 1ml long, 3ml, 5ml, 10ml, 20ml and 50ml. As Halvorsen says, “if you have a syringe, we would like to make it more compact, whatever the size is.”
They are licensing the IP rather than manufacturing — starting with an unnamed saline flush manufacturer — and have won a Red Dot Design Award in the Medical Devices and Technology Concept category. Between 7 and 10 billion prefilled syringes are used every year, which is why a component you can hold in your palm is worth 3.5 years of engineering.
One rod, moved to the side. That is the whole innovation. Sometimes that is all it takes.
Source: Reported by Lisa McTigue Pierce for Packaging Digest, 24 August 2026 — “Compact Syringe Saves Up To 35% in Supply Chain Costs”
